Nasdaq:US$13.81 (+0.07) | HKEX:HK$21.95 (-0.15) | AIM:£2.27 (-0.06)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 13 Jul 2009

Phase II Crohn’s Disease Trial for HMPL-004 Delivers Encouraging Results

1 items
a090713